International Nonproprietary Names for Pharmaceutical Substances (INN).
- Published in:
- WHO Drug Information, 2021, v. 35, n. 3, p. 707
- Publication type:
- Article
Works matching IS 10109609 AND DT 2021 AND VI 35 AND IP 3
Results: 8
1
2
WHO BIOWAIVER PROJECT - PREPARATION FOR CYCLE V (2022): PRIORITIZATION EXERCISE OF ACTIVE PHARMACEUTICAL INGREDIENTS ON THE WHO MODEL LIST OF ESSENTIAL MEDICINES FOR SOLUBILITY DETERMINATION AND BIOPHARMACEUTICS CLASSIFICATION SYSTEM-BASED CLASSIFICATION.
- Published in:
- WHO Drug Information, 2021, v. 35, n. 3, p. 606
- Publication type:
- Article
3
BENZATHINE BENZYLPENICILLIN FOR INJECTION (BENZATHINI BENZYLPENICILLINI AD INJECTIONEM).
- Published in:
- WHO Drug Information, 2021, v. 35, n. 3, p. 701
- Publication type:
- Article
4
DOLUTEGRAVIR DISPERSIBLE TABLETS ( DOLUTEGRAVIRI COMPRESSI DISPERSIBILI).
- Published in:
- WHO Drug Information, 2021, v. 35, n. 3, p. 684
- Publication type:
- Article
5
WHO GOOD PRACTICES FOR RESEARCH AND DEVELOPMENT FACILITIES OF PHARMACEUTICAL PRODUCTS.
- Published in:
- WHO Drug Information, 2021, v. 35, n. 3, p. 637
- Publication type:
- Article
6
IAEA/WHO GUIDELINE ON GOOD MANUFACTURING PRACTICES FOR INVESTIGATIONAL RADIOPHARMACEUTICAL PRODUCTS.
- Published in:
- WHO Drug Information, 2021, v. 35, n. 3, p. 612
- Publication type:
- Article
7
BENZATHINE BENZYLPENICILLIN TETRAHYDRATE ( BENZATHINI BENZYLPENICILLINUM TETRAHYDRICUM).
- Published in:
- WHO Drug Information, 2021, v. 35, n. 3, p. 691
- Publication type:
- Article
8
WHO GOOD MANUFACTURING PRACTICES FOR INVESTIGATIONAL PRODUCTS.
- Published in:
- WHO Drug Information, 2021, v. 35, n. 3, p. 662
- Publication type:
- Article